Deliver Biosciences
PrivateLast Round
Grant
Mar 1, 2022
Company Overview
Deliver Biosciences operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Grant round in March 2022.
Deliver Biosciences is a biotechnology company that develops a nanoparticle-based delivery platform to genetically engineer cells inside patients for the creation of scalable, affordable, and potent cell and gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Deliver Biosciences Comparables
Compare Deliver Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ViaNautis Bio | 82% | |
| Ensoma | 79% | |
| AbbVie | 77% |
For institutional investors. Book with your work email.
Deliver Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 1, 2022 | ||||
| Seed | Dec 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Deliver Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deep Science Ventures | Seed |
| SciFounders | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 25, 2025
Monthly visitors grew 119% MoM.
- Mar 1, 2022
Received grant funding to support operations.
For institutional investors. Book with your work email.
Deliver Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Deliver Biosciences's valuation, stock price, and market status.
Is Deliver Biosciences a public or private company?
Deliver Biosciences is a private company.
What is the current stock price of Deliver Biosciences?
Deliver Biosciences is a private company, so its shares have no public market price. Caplight tracks Deliver Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Deliver Biosciences worth (valuation)?
Valuation information for Deliver Biosciences is not publicly available.
Can I buy Deliver Biosciences stock?
Deliver Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Deliver Biosciences's last funding round?
Deliver Biosciences's most recent funding round was Grant on March 1, 2022.
Who are the main investors in Deliver Biosciences?
Key investors in Deliver Biosciences include Deep Science Ventures, SciFounders.
Will Deliver Biosciences IPO soon?
No public IPO plans have been announced for Deliver Biosciences.
How can I track Deliver Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Deliver Biosciences's shares on secondary markets.